Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Perspectives on Telemedicine Visits Reported by Patients With Cancer.
Doshi SD, Charvadeh YK, Seier K, Bange EM, Daly B, Lipitz-Snyderman A, Polubriaginof FCG, Buckley M, Kuperman G, Stetson PD, Schrag D, Morris MJ, Panageas KS. Doshi SD, et al. Among authors: panageas ks. JAMA Netw Open. 2024 Nov 4;7(11):e2445363. doi: 10.1001/jamanetworkopen.2024.45363. JAMA Netw Open. 2024. PMID: 39546309 Free PMC article.
Oncology Clinicians' Perspectives of a Remote Patient Monitoring Program: A Multi-Modal Case Study Approach.
Mazzella-Ebstein AM, Daly R, Huang J, Bernal C, Wilhelm C, Panageas KS, Holland J, Salvaggio R, Ackerman J, Cracchiolo J, Kuperman G, Mao J, Begue A, Barton-Burke M. Mazzella-Ebstein AM, et al. Among authors: panageas ks. JMIR Hum Factors. 2024 Sep 23. doi: 10.2196/60585. Online ahead of print. JMIR Hum Factors. 2024. PMID: 39446017 Free article.
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma.
Grommes C, Nandakumar S, Schaff LR, Gavrilovic I, Kaley TJ, Nolan CP, Stone J, Thomas AA, Tang SS, Wolfe J, Bozza A, Wongchai V, Hyde A, Barrett E, Lynch EA, Madzsar JT, Lin A, Piotrowski AF, Pentsova E, Francis JH, Hatzoglou V, Schultz N, Reiner AS, Panageas KS, DeAngelis LM, Mellinghoff IK. Grommes C, et al. Among authors: panageas ks. Clin Cancer Res. 2024 Sep 13;30(18):4005-4015. doi: 10.1158/1078-0432.CCR-24-0605. Clin Cancer Res. 2024. PMID: 38995739 Clinical Trial.
Transforming patient-centered cancer care using telehealth: the MATCHES Center.
Bange EM, Daly RM, Lipitz-Snyderman A, Kuperman G, Polubriaginof FCG, Liebertz C, Doshi SD, Stevanovic K, Chan K, Bernal C, Charvadeh YK, Chen Y, Chimonas S, Stetson P, Schrag D, Morris MJ, Panageas KS. Bange EM, et al. Among authors: panageas ks. J Natl Cancer Inst Monogr. 2024 Jun 26;2024(64):76-82. doi: 10.1093/jncimonographs/lgae004. J Natl Cancer Inst Monogr. 2024. PMID: 38924792
Early On-Treatment Assessment of T Cells, Cytokines, and Tumor DNA with Adaptively Dosed Nivolumab + Ipilimumab: Final Results from the Phase 2 ADAPT-IT Study.
Smithy JW, Kalvin HL, Ehrich FD, Shah R, Adamow M, Raber V, Maher CA, Kleman J, McIntyre DAG, Shoushtari AN, Betof Warner A, Callahan MK, Momtaz P, Eton O, Nair S, Wolchok JD, Chapman PB, Berger MF, Panageas KS, Postow MA. Smithy JW, et al. Among authors: panageas ks. Clin Cancer Res. 2024 Aug 15;30(16):3407-3415. doi: 10.1158/1078-0432.CCR-23-3643. Clin Cancer Res. 2024. PMID: 38767650 Clinical Trial.
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.
Friedman JS, Durham BH, Reiner AS, Yabe M, Petrova-Drus K, Dogan A, Pulitzer M, Busam KJ, Francis JH, Rampal RK, Ulaner GA, Reddy R, Yeh R, Hatzoglou V, Lacouture ME, Rotemberg V, Mazor RD, Hershkovitz-Rokah O, Shpilberg O, Goyal G, Go RS, Abeykoon JP, Rech K, Morlote D, Fidai S, Gannamani V, Zia M, Abdel-Wahab O, Panageas KS, Rosenblum MK, Diamond EL. Friedman JS, et al. Among authors: panageas ks. Br J Haematol. 2024 Jul;205(1):127-137. doi: 10.1111/bjh.19462. Epub 2024 Apr 12. Br J Haematol. 2024. PMID: 38613141
288 results